John Paulson’s portfolio: Paulson & Co 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026

Q4 2019 filing in brief

In its Q4 2019 13F, filed February 14, 2020, Paulson & Co reported $4.6B across 37 US positions. The largest: BHC (13.5%), GLD (13.3%), ALLERGAN PLC (11.0%), DISCKUSD (7.2%), HORIZON THERAPEUTICS PUB LTD (6.4%). In the quarter it opened 6 positions, sold out of 14, added to 2 and trimmed 5; positions opened and sold out came to 30.8% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 14, 2020

  • 6 New
  • 2 Added
  • 5 Trimmed
  • 14 Exited

37 positions at December 31, 2019. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1BHCBAUSCH HEALTH COS INC$624M20.8M13.46%0.0%Held
2GLDSPDR GOLD TRUST$617M4.3M13.33%0.0%Held
3—ALLERGAN PLC$509M2.7M10.99%−9.2%Trimmed
4DISCKUSDDISCOVERY INC$333M10.9M7.19%0.0%Held
5—HORIZON THERAPEUTICS PUB LTD$296M8.2M6.38%0.0%Held
6AU3EURANGLOGOLD ASHANTI LTD$286M12.8M6.16%0.0%Held
7TAKTAKEDA PHARMACEUTICAL CO LTD$261M13.2M5.64%0.0%Held
80VVBVIACOMCBS INC$252M6.0M5.44%—New
9—MYLAN N V$241M12.0M5.21%0.0%Held
10AAMIBRIGHTSPHERE INVT GROUP INC$204M20.0M4.41%0.0%Held
11NGNOVAGOLD RES INC$197M22.0M4.25%0.0%Held
12DISHDISH NETWORK CORP$176M5.0M3.81%0.0%Held
13—SPRINT CORPORATION$83M16.0M1.80%+27.2%Added
14PCRXPACIRA BIOSCIENCES$78M1.7M1.68%0.0%Held
15TSUTIM PARTICIPACOES S A$71M3.7M1.53%0.0%Held
16—ENDO INTL PLC$40M8.6M0.87%0.0%Held
17ABXBARRICK GOLD CORPORATION$38M2.0M0.82%+0.2%Held
18AEMAGNICO EAGLE MINES LTD$37M607.6K0.81%0.0%Held
19TMQTRILOGY METALS INC NEW$37M14.3M0.80%0.0%Held
20THMINTERNATIONAL TOWER HILL MIN$32M59.6M0.69%0.0%Held
21WCGEURWELLCARE HEALTH PLANS INC$31M93.0K0.66%−83.4%Trimmed
22PVG1EURPRETIUM RES INC$29M2.6M0.62%—New
23SSRMSSR MNG INC$22M1.2M0.48%0.0%Held
24NMRKNEWMARK GROUP INC$21M1.6M0.45%−22.5%Trimmed
25TECD1USDTECH DATA CORP$19M133.4K0.41%—New
26OSG1EUROVERSEAS SHIPHOLDING GROUP I$19M8.3M0.41%0.0%Held
27TIFEURTIFFANY & CO NEW$18M134.0K0.39%—New
28CZRCAESARS ENTMT CORP$16M1.2M0.35%−59.7%Trimmed
29LOGMEURLOGMEIN INC$10M122.3K0.23%—New
30SASEABRIDGE GOLD INC$10M700.0K0.21%0.0%Held
31IAGIAMGOLD CORP$7M1.9M0.15%0.0%Held
32IPHSEURINNOPHOS HOLDINGS INC$5M160.4K0.11%—New
33QEPQEP RES INC$4M808.5K0.08%−20.0%Trimmed
34SDSANDRIDGE ENERGY INC$3M666.5K0.06%0.0%Held
35ZAYOEURZAYO GROUP HLDGS INC$2M72.1K0.05%0.0%Held
36LEALEAR CORP$1M10.1K0.03%0.0%Held
37SYNESYNTHESIS ENERGY SYS INC$944K165.6K0.02%+6.0%Added
14 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
CELGCELGENE CORP$317M3.2M
AABAUSDALTABA INC$148M7.6M
ONCEEURSPARK THERAPEUTICS INC$139M1.4M
TSLATESLA INCput option$120M500.0K
BID1EURSOTHEBYS$106M1.9M
CPE3EURCALLON PETE CO DEL$94M21.6M
VSMEURVERSUM MATLS INC$53M1.0M
VIABVIACOM INC NEW$52M2.1M
PSDOEURPRESIDIO INC$45M2.6M
UTXZUNITED TECHNOLOGIES CORP$27M200.0K
PCGPG&E CORP$26M2.6M
—INTERNATIONAL SEAWAYS INC$14M719.9K
LYFTLYFT INC$6M151.2K
TMUST MOBILE US INC$3M37.0K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.